S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$0.00
$0.03
$6.74
$4.17M0.457.75 million shsN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$0.50
$0.93
$0.45
$5.56
$157.98M1.04293,248 shs269,507 shs
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$19.89
-0.6%
$18.66
$10.31
$20.89
$608.13M2.06119,814 shs129,789 shs
Sharecare, Inc. stock logo
SHCR
Sharecare
$0.63
-4.5%
$0.89
$0.48
$1.80
$237.27M0.263.19 million shs2.24 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
0.00%0.00%0.00%0.00%-99.32%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
+0.18%-15.85%-48.88%-58.60%-58.60%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
-0.60%-2.26%+0.81%+26.61%+58.49%
Sharecare, Inc. stock logo
SHCR
Sharecare
-4.20%-18.82%-35.47%-33.02%-62.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
0.8772 of 5 stars
3.32.00.00.00.60.80.6
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.7361 of 5 stars
1.34.00.00.02.73.33.1
Sharecare, Inc. stock logo
SHCR
Sharecare
1.8883 of 5 stars
3.03.00.00.01.61.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
2.50
Moderate Buy$4.75848.10% Upside
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.67
Moderate Buy$18.75-5.73% Downside
Sharecare, Inc. stock logo
SHCR
Sharecare
2.00
Hold$1.0057.75% Upside

Current Analyst Ratings

Latest PNTG, SHCR, PEAR, and PIII Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Sharecare, Inc. stock logo
SHCR
Sharecare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$1.50 ➝ $1.00
4/1/2024
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/1/2024
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
4/1/2024
Sharecare, Inc. stock logo
SHCR
Sharecare
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/14/2024
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$9.00 ➝ $4.50
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$18.00 ➝ $22.00
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$16.00 ➝ $21.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$12.69M0.00N/AN/A$0.22 per share0.00
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$1.27B0.12$0.09 per share5.31$0.45 per share1.11
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$544.89M1.11$0.78 per share25.57$4.86 per share4.09
Sharecare, Inc. stock logo
SHCR
Sharecare
$445.25M0.51N/AN/A$1.22 per share0.52

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
-$75.49M-$0.22N/AN/AN/A-594.70%-217.85%-95.20%N/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$57.77M-$0.65N/AN/AN/A-4.56%-120.85%-6.54%5/8/2024 (Estimated)
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$13.38M$0.4445.2023.132.112.46%12.78%3.36%5/2/2024 (Estimated)
Sharecare, Inc. stock logo
SHCR
Sharecare
-$128.50M-$0.37N/AN/AN/A-28.86%-17.11%-12.33%5/8/2024 (Estimated)

Latest PNTG, SHCR, PEAR, and PIII Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/28/202412/31/2023
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.19$0.18-$0.01$0.22$136.79 million$145.95 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A
Sharecare, Inc. stock logo
SHCR
Sharecare
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/A
1.48
1.48
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
0.76
0.55
0.55
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.44
1.12
1.12
Sharecare, Inc. stock logo
SHCR
Sharecare
N/A
2.30
2.30

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
71.17%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
7.75%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%
Sharecare, Inc. stock logo
SHCR
Sharecare
35.08%

Insider Ownership

CompanyInsider Ownership
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
30.70%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
17.06%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
10.30%
Sharecare, Inc. stock logo
SHCR
Sharecare
29.27%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
300142.74 million98.92 millionNot Optionable
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
400315.90 million262.01 millionNot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5,79130.39 million27.26 millionOptionable
Sharecare, Inc. stock logo
SHCR
Sharecare
3,352358.57 million253.62 millionOptionable

PNTG, SHCR, PEAR, and PIII Headlines

SourceHeadline
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sharecare, Inc. (SHCR) Regarding Possible Securities Fraud ViolationsShareholder Rights Advocates at Levi & Korsinsky Investigate Sharecare, Inc. (SHCR) Regarding Possible Securities Fraud Violations
accesswire.com - April 18 at 3:40 PM
Lost Money on Sharecare, Inc.(SHCR)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyLost Money on Sharecare, Inc.(SHCR)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
accesswire.com - April 18 at 3:40 PM
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCRROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCR
stockhouse.com - April 18 at 2:14 PM
Levi & Korsinsky Reminds Sharecare Investors of the Ongoing Investigation into Potential Violations of Securities Laws - SHCRLevi & Korsinsky Reminds Sharecare Investors of the Ongoing Investigation into Potential Violations of Securities Laws - SHCR
accesswire.com - April 18 at 11:30 AM
Shareholders that lost money on Sharecare, Inc. (SHCR) should contact Levi & Korsinsky about Securities Fraud Investigation - SHCRShareholders that lost money on Sharecare, Inc. (SHCR) should contact Levi & Korsinsky about Securities Fraud Investigation - SHCR
accesswire.com - April 18 at 8:30 AM
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the FirmINVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 18 at 8:00 AM
ATTENTION SHCR SHAREHOLDERS: Investors who lost money on Sharecare, Inc. are urged to contact Levi & Korsinsky about an ongoing investigationATTENTION SHCR SHAREHOLDERS: Investors who lost money on Sharecare, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
accesswire.com - April 17 at 8:07 PM
SHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCRSHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCR
prnewswire.com - April 17 at 7:30 PM
Investors who lost money on Sharecare, Inc. should contact Levi & Korsinsky about an ongoing investigation - SHCRInvestors who lost money on Sharecare, Inc. should contact Levi & Korsinsky about an ongoing investigation - SHCR
accesswire.com - April 17 at 11:30 AM
Sharecare (SHCR) Price Target Decreased by 31.85% to 1.96Sharecare (SHCR) Price Target Decreased by 31.85% to 1.96
msn.com - April 17 at 9:39 AM
Lost Money on Sharecare, Inc.(SHCR)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationLost Money on Sharecare, Inc.(SHCR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
accesswire.com - April 16 at 1:30 PM
An Investigation Has Commenced on Behalf of Sharecare, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SHCR LossesAn Investigation Has Commenced on Behalf of Sharecare, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SHCR Losses
accesswire.com - April 16 at 11:30 AM
Sharecare, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - SHCRSharecare, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - SHCR
accesswire.com - April 16 at 10:30 AM
Sharecare (NASDAQ:SHCR) Price Target Lowered to $1.00 at Morgan StanleySharecare (NASDAQ:SHCR) Price Target Lowered to $1.00 at Morgan Stanley
americanbankingnews.com - April 16 at 3:34 AM
SHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCRSHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation - SHCR
tmcnet.com - April 15 at 5:15 PM
SHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation – SHCRSHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation – SHCR
businesswire.com - April 15 at 1:40 PM
Sharecare (NASDAQ:SHCR) Price Target Cut to $1.00Sharecare (NASDAQ:SHCR) Price Target Cut to $1.00
marketbeat.com - April 15 at 1:39 PM
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the FirmINVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 15 at 3:00 AM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 13 at 6:00 AM
Sharecare, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SHCRSharecare, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SHCR
accesswire.com - April 12 at 11:45 AM
Levi & Korsinsky Announces an Investigation on Behalf of Sharecare, Inc. (SHCR) Shareholders Who May Have Been Affected by FraudLevi & Korsinsky Announces an Investigation on Behalf of Sharecare, Inc. (SHCR) Shareholders Who May Have Been Affected by Fraud
accesswire.com - April 12 at 11:45 AM
Shareholders That Lost Money on Sharecare, Inc.(SHCR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - SHCRShareholders That Lost Money on Sharecare, Inc.(SHCR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - SHCR
accesswire.com - April 12 at 10:15 AM
SHCR STOCK ALERT: Levi & Korsinsky Notifies Sharecare, Inc. Investors of an Ongoing InvestigationSHCR STOCK ALERT: Levi & Korsinsky Notifies Sharecare, Inc. Investors of an Ongoing Investigation
accesswire.com - April 12 at 10:00 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sharecare, Inc. - SHCRSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sharecare, Inc. - SHCR
prnewswire.com - April 12 at 9:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Pear Therapeutics logo

Pear Therapeutics

NASDAQ:PEAR
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
P3 Health Partners logo

P3 Health Partners

NASDAQ:PIII
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
The Pennant Group logo

The Pennant Group

NASDAQ:PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Sharecare logo

Sharecare

NASDAQ:SHCR
Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to enhance their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. The company was founded in 2009 and is headquartered in Atlanta, Georgia.